The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Global cancer statistics
Open accessAbstract
The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11% of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278
Cited by
Items 401–423 of 423
Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival
Spreafico, A., Coate, L., Zhai, R., Xu, W., Chen, Z.-F., Chen, Z., Patel, D., Tse, B., Brown, M. C., Heist, R. S., et al. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2016.11.009 · Cited by 19
Lu, X., Lin, B., Xu, N., Huang, H., Wang, Y., & Lin, J.-M. (2020) · Talanta · doi:10.1016/j.talanta.2020.120732 · Cited by 23
Nuclear expression of claudin‑3 in human colorectal adenocarcinoma cell lines and tissues
Tokuhara, Y., Morinishi, T., Matsunaga, T., Sakai, M., Sakai, T., Ohsaki, H., Kadota, K., Kushida, Y., Haba, R., & Hirakawa, E. (2017) · Oncology Letters · doi:10.3892/ol.2017.7281 · Cited by 23
Gnagnarella, P., Dragà, D., Baggi, F., Simoncini, M. C., Sabbatini, A., Mazzocco, K., Bassi, F. D., Pravettoni, G., & Maisonneuve, P. (2016) · Trials · doi:10.1186/s13063-016-1487-x · Cited by 22
Chen, L., Dong, B., Zhang, Q., Mao, X., Lin, W., Ruan, G., Kang, Y., & Sun, P. (2020) · Medical Oncology · doi:10.1007/s12032-020-01363-z · Cited by 22
Dolan, R. D., Maclay, J. D., Abbass, T., Colville, D., Buali, F., MacLeod, N., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-77269-7 · Cited by 22
Antidepressants and Gastric Cancer: A Nationwide Population-Based Nested Case-Control Study
Hsieh, Y.-H., Chiu, W.-C., Lin, C.-F., Chan, H.-L., Liang, H.-Y., Lee, Y., McIntyre, R. S., & Chen, V. C.-H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143668 · Cited by 22
Therapeutic inhibition of phospholipase D1 suppresses hepatocellular carcinoma
Xiao, J., Sun, Q., Bei, Y., Zhang, L., Dimitrova-Shumkovska, J., Lv, D., Yang, Y., Cao, Y., Zhao, Y., Song, M., et al. (2016) · Clinical Science · doi:10.1042/cs20160087 · Cited by 21
Li, C., Zhao, N., An, L., Dai, Z., Chen, X., Yang, F., You, Q., Di, B., Hu, C., & Xu, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.013 · Cited by 20
Romero-Benavides, J. C., Bailon-Moscoso, N., Parra-Delgado, H., Ramirez, M. I., Villacis, J., Cabrera, H., Gonzalez-Arevalo, G., Cueva, R., Zentella-Dehesa, A., Ratovitski, E. A., et al. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2106-4 · Cited by 17
McMiller, T. L., Besharati, S., Yarchoan, M., Zhu, Q., Ünsal-Kaçmaz, K., Xu, K., Lee, J., Bhaijee, F., Engle, L. L., Taube, J. M., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010201 · Cited by 16
Kawanishi, M., Fukuda, T., Shimomura, M., Inoue, Y., Wada, T., Tasaka, R., Yasui, T., & Sumi, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.8598 · Cited by 16
Grégoire, C., Faymonville, M.-E., Vanhaudenhuyse, A., Charland-Verville, V., Jerusalem, G., & Bragard, I. (2018) · BMC Cancer · doi:10.1186/s12885-018-5046-6 · Cited by 14
Clinical significance of serum mitochondrial DNA in lung cancer
Hou, Y.-L., Chen, J.-J., Wu, Y.-F., Xue, C.-J., Li, F.-Z., Zheng, Q., & Chen, H. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.009 · Cited by 13
Rapamycin inhibited the function of lung CSCs via SOX2
Xie, L.-X., Sun, F.-F., He, B.-F., Zhan, X.-F., Song, J., Chen, S.-S., Yu, S.-C., & Ye, X.-Q. (2016) · Tumor Biology · doi:10.1007/s13277-015-4341-y · Cited by 12
Jiang, B., Zhou, L., Lu, J., Wang, Y., Liu, C., Liang, Z., Zhou, W., You, L., & Guo, J. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15244 · Cited by 9
He, Y., Chen, F., Cai, Y., & Chen, S. (2016) · Cell Biology International · doi:10.1002/cbin.10593 · Cited by 8
RetractedBama, E. S., Grace, V. M. B., Sundaram, V., & Jesubatham, P. D. (2019) · 3 Biotech · doi:10.1007/s13205-019-1692-x · Cited by 8
Esmali, A., & Alizadeh, M. (2015) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/1898 · Cited by 7
Guo, H., Yang, J., Liu, S., Qin, T., Zhao, Q., Hou, X., & Ren, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.1957645 · Cited by 7
Comparison of Different Classification Methods for Breast Cancer Subtypes Prediction
Xu, J., Wu, P., Chen, Y., & Zhang, L. (2018) · 2018 International Conference on Security, Pattern Analysis, and Cybernetics (SPAC) · doi:10.1109/spac46244.2018.8965553 · Cited by 5
Alcoholic Liver Disease Accelerates Early Hepatocellular Cancer in a Mouse Model
Szabo, G. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-98788-0_5 · Cited by 4
Hunter, M. S., Sharpley, C. F., Stefanopoulou, E., Yousaf, O., Bitsika, V., & Christie, D. R. H. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.09.014 · Cited by 3
Metadata
- Authors
- Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2011-02-04
- Volume
- 61
- Issue
- 2
- Pages
- 69-90
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2106787323
- Cited by
- 54,679
- References
- 3
- FWCI
- 2387.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
